- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04494620
Evaluating Oral Visual Inspection in the Control of Oral Cancer
July 28, 2020 updated by: International Agency for Research on Cancer
Randomized Intervention Trial to Evaluate Oral Visual Inspection in the Control of Oral Cancer
Cluster-randomized controlled trial in Trivandrum district, Kerala, India to evaluate the effect of triennial screening for oral cavity cancer using visual inspection on oral cancer mortality.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The study population consisted of 13 administrative regions (clusters) in Trivandrum district, Kerala, southern Indian.
7 clusters were randomly assigned to the intervention arm (3 rounds of oral visual inspection conducted 3 years apart) and were compared to the remaining 6 clusters assigned to a control arm that received standard of care.
The eligibility criteria were all healthy subjects aged 35 and older, without a personal history of oral cancer.
Informed consent was signed by each participant.
The intervention arm consisted of 96,517 participants and the control group consisted of 95,356 participants.
Study Type
Interventional
Enrollment (Actual)
191873
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
35 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria: Residing in 13 study clusters in Trivandrum City, Kerala
Exclusion Criteria:
- Diagnosis with oral cancer prior to study
- Bedridden subjects
- Subjects suffering from open tuberculosis or other debilitating diseases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control Arm
Standard of Care
|
|
|
Active Comparator: Intervention Arm
Visual Inspection of Oral Cavity for Precancers and Cancer
|
Participants were invited for 3 rounds of oral cavity cancer screening, conducted 3-years apart.
Screening was conducted by health workers trained to perform visual inspection of the oral mucosa and identify potential precancerous lesions or oral cancer.
Lesions found were referred to a weekly clinic for further evaluation by dentists and oncologists with experience in the diagnosis of oral lesions.
Oral precancerous lesions were surgically excised whenever possible and those with confirmed oral cancer were referred for appropriate treatment with surgery, radiotherapy, and/or chemotherapy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Oral Cancer Death Rate
Time Frame: 15 years
|
Information on all deaths were collected from the municipal and district death registers, hospital medical records, death records of churches and mosques, hospital visits by the population cancer registry staff and by project health workers.
Cancer cases were coded by the ICD-O 3rd edition codes and cause of death was coded using ICD-10 by the registry and project staff blinded to study group allocation.
Deaths were attributed to oral cancer if the patient had histologically or clinically confirmed oral cancer, lymph nodes or distant metastasis at the time of death or had died due to complications of oral cancer treatment.
|
15 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Oral Cavity Cancer Incidence
Time Frame: 15 years
|
Information on incident oral cancer cases were obtained from the Trivandrum population-based cancer registry, hospital cancer registry of the RCC and medical records departments of other hospitals treating oral cancer patients.
Collection of information was blinded to study group assignment of cases.
The staging of oral cancers was done according to the UICC TNM staging system.
|
15 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Kunnambath Ramadas, MD, PhD, Regional Cancer Centre, Trivandrum, India
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Sankaranarayanan R, Ramadas K, Thara S, Muwonge R, Thomas G, Anju G, Mathew B. Long term effect of visual screening on oral cancer incidence and mortality in a randomized trial in Kerala, India. Oral Oncol. 2013 Apr;49(4):314-21. doi: 10.1016/j.oraloncology.2012.11.004. Epub 2012 Dec 21.
- Sankaranarayanan R, Ramadas K, Thomas G, Muwonge R, Thara S, Mathew B, Rajan B; Trivandrum Oral Cancer Screening Study Group. Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial. Lancet. 2005 Jun 4-10;365(9475):1927-33. doi: 10.1016/S0140-6736(05)66658-5.
- Cheung LC, Ramadas K, Muwonge R, Katki HA, Thomas G, Graubard BI, Basu P, Sankaranarayanan R, Somanathan T, Chaturvedi AK. Risk-Based Selection of Individuals for Oral Cancer Screening. J Clin Oncol. 2021 Feb 20;39(6):663-674. doi: 10.1200/JCO.20.02855. Epub 2021 Jan 15.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 1996
Primary Completion (Actual)
December 31, 2004
Study Completion (Actual)
December 31, 2014
Study Registration Dates
First Submitted
July 16, 2020
First Submitted That Met QC Criteria
July 28, 2020
First Posted (Actual)
July 31, 2020
Study Record Updates
Last Update Posted (Actual)
July 31, 2020
Last Update Submitted That Met QC Criteria
July 28, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RCC-IEC-Sept 2002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Oral Cancer
-
Anil ChaturvediNational Taiwan University HospitalRecruitingOral Cancer | Oral Cancer Screening | Oral PrecancerTaiwan
-
Royal Surrey County Hospital NHS Foundation TrustCompleted
-
King's College LondonGuy's and St Thomas' NHS Foundation TrustNot yet recruitingOral Cancer | Dysplasia | Mouth Cancer | Oral Lesions | Oral Pre-cancerUnited Kingdom
-
Combined Military Hospital, PakistanNational University of Medical Sciences, PakistanCompletedOral Cancer , Oral Squamous Cell Carcinoma, Oral Cavity CancerPakistan
-
University of WashingtonBlaze Bioscience Inc.TerminatedStage III Lip and Oral Cavity Cancer AJCC v8 | Oral Cavity Squamous Cell Carcinoma | Stage I Lip and Oral Cavity Cancer AJCC v8 | Stage II Lip and Oral Cavity Cancer AJCC v8 | Stage IVA Lip and Oral Cavity Cancer AJCC v8United States
-
Centre Francois BaclesseTerminatedCancer | Cognitive Function | Compliance | Oral TherapiesFrance
-
University of Michigan Rogel Cancer CenterRecruitingStage III Lip and Oral Cavity Cancer AJCC v8 | Oral Cavity Squamous Cell Carcinoma | Stage I Lip and Oral Cavity Cancer AJCC v8 | Stage II Lip and Oral Cavity Cancer AJCC v8 | Stage IVA Lip and Oral Cavity Cancer AJCC v8United States
-
National Cancer Institute (NCI)CompletedLip and Oral Cavity Cancer | Oropharyngeal Cancer | Tongue Cancer | Oral LeukoplakiaUnited States
-
Pai PangActive, not recruitingOral Cancer Patients After Selective Neck DissectionChina
-
Helsinki University Central HospitalKarolinska Institutet; University of HelsinkiCompletedPeriodontal Diseases | Biomarker in Early Diagnosis | Oropharyngeal Cancers | Oral Cancer , Oral Squamous Cell Carcinoma, Oral Cavity CancerFinland
Clinical Trials on Visual Inspection of Oral Cavity for Precancers and Cancer
-
Centre Hospitalier Universitaire, AmiensRegional Council Picardie; Picardy - Regional health agency (ARS); Regional Observatory... and other collaboratorsRecruiting
-
Tata Memorial HospitalEmory University; American Cancer Society, Inc.UnknownPrecancerous Conditions | Oral CancerIndia
-
Xinqiao Hospital of ChongqingCompletedNasopharyngeal CarcinomaChina
-
University of New MexicoSociety of Urologic Nurses and AssociatesCompletedUrinary Incontinence, UrgeUnited States
-
Lund UniversityAddis Ababa University; Armauer Hansen Research Institute, Ethiopia; Adama Hospital...RecruitingCervical Cancer | STI | Microbiota | Human Papilloma VirusEthiopia
-
Liaquat University of Medical & Health SciencesSindh Higher Education CommissionRecruitingThe Study Focuses on the Saliva as Potential Source of Early Detection of Oral CancerPakistan
-
University of Nove de JulhoNot yet recruiting
-
University of StellenboschStanford UniversityCompletedHyperbilirubinemia | Neonatal JaundiceSouth Africa
-
University of California, San FranciscoKenya Medical Research InstituteCompletedCervical Cancer | Cervical Intraepithelial Neoplasia | HIVKenya
-
Mylan Specialty, LPTerminatedLiver Failure | Amatoxin Poisoning | Amanita Poisoning | Mushroom PoisoningUnited States